June 13, 2016 – – JMS Air Conditioning and Heating, an HVAC services company in Van Nuys, CA, has engaged in an aggressive online marketing campaign together with their partner, Local Visibility Consultants. As part of this campaign, they have released a new YouTube video that shows a customer review of their services for heating and air conditioning systems, like replacement of thermostats. The video can be viewed at https://www.youtube.com/watch?v=4jZpLdGwjiY.

Alex Weiss from Local Visibility Consultants says: “We have been working together with JMS Air Conditioning to give them greater online visibility. To do this, we have helped them build a comprehensive website and social media campaign. Additionally, we have now started their video marketing campaign, with the first YouTube video having been launched. It’s good to see that our campaign is working, and that the company is already noticing a significant increase in new clients.”

The new video is a strong element of the company’s reputation marketing campaign. The company has received a number of very positive reviews, and the new video highlights just one of them. This is an opportunity for JMS Air Conditioning to further spread its good name, and also to express gratitude towards their customers. They aim to highlight further reviews in the same manner.

“We work very hard to satisfy everyone,” says a representative from JMS Air Conditioning. “Our business thrives on the happiness of our clients. So when someone writes us to tell us we did a great job, we love to show our appreciation by sharing the review.”

In the review, Daniel H. states: “This is the best AC/Heating company in the LA area – hands down. They are on time, tell it like it is (good or bad news) and are extremely professional. Our technician, Marco, was a genius. He helped fix a big AC problem. I used 2 other companies before JMS and there was no comparison.”

JMS Air Conditioning and Heating looks forward to receiving more reviews and creating further videos to highlight these. Those who have worked with the air conditioning company continue to be very pleased about the services that they have received to help fix their HVAC systems.

JMS Air Conditioning and Heating is located at 7640 Burnet Avenue Van Nuys, CA 91405.

To contact JMS Air Conditioning and Heating call (818) 501-6750.

###

Contact Local Visibiity Consultants:

Alex Weiss
(323) 230-4582
info@localvc.net

ReleaseID: 60009931

June 13, 2016 – – JMS Air Conditioning and Heating, which provides high quality but affordable cooling services, has been working with Local Visibility Consultants in building their online marketing campaign. Having recently upgraded and relaunched the company’s website, they are now focusing on their social media campaign. Through this, they aim to increase local media marketing, particularly in the Granada Hills, CA area. The Twitter page can be accessed through https://twitter.com/JMSAcAndHeating.

A representative from Local Visibility Consultants says: “JMS has been one of our most challenging clients to date. As an HVAC business, they have always relied almost fully on word of mouth advertising and had hence done almost no work on building an online presence. We basically had to start from scratch. Slowly but surely, we’re getting there and it is very good to see that each step we have taken has improved the company’s visibility and reputation.”

The new JMS Twitter page is used for a variety of reasons. First of all, it enables the company to share industry-relevant news, enabling owners of domestic and commercial properties to be fully aware of any new developments in the world of heating and cooling. Secondly, the page is used to share any information that is relevant specifically to JMS itself, including staff expansion, new service areas, and more.

Finally, the page is also used to share the kind words that others have shared about JMS. Vanessa D.M. is one of the many people who reviewed the company on Yelp and has had her review included on the Twitter page as well. “JMS installed a great AC and heating unit in my home. Fast service. Ohad was very attentive, made sure I was getting the right unit for my home. Claudia in the office was quick to call and set up my appointment and was very friendly. She answered my questions and concerns in detail. Overall great service, the guys whom installed my unit were clean and quick. Thank you Ohad, Claudia and the EIT crew for their service.”

People are encouraged to follow the Twitter page to always have an affordable, high quality heating and cooling service at their disposal.

JMS Air Conditioning and Heating is located at 7640 Burnet Avenue Van Nuys, CA 91405.

To contact JMS Air Conditioning and Heating call (818) 501-6750.

###

Contact Local Visibiity Consultants:

Alex Weiss
(323) 230-4582
info@localvc.net

ReleaseID: 60010048

June 13, 2016 – – TheProductLaywers.com reports on adverse side effects that have been reported by patients concerning IVC filters. The FDA has reported that between 2005 and 2010, 921 adverse events related to IVC filters have been submitted through the FDA’s system. Of those incidents, the reports state that 328 involved device migration, 146 involved embolizations, 70 involved perforations and 56 involved filter fracture. The FDA has also noted that many of these complications may be related to the amount of time an IVC filter is allowed to remain in place.

The devices are designed to “catch” blood clots before they reach the pulmonary artery. The small conical nets capture passing blood clots and stop them from reaching the vessels they could block.

A number of patients who have claimed to suffer from complications have filed legal claims against manufacturers for poor design, manufacturing and failing to warn of risks. Lawsuits against Bard were first filed in 2012 in California and Pennsylvania state courts and were combined into a Multidistrict Litigation (MDL) Panel in the U.S. District Court of Arizona in 2015. Those cases against Cook Medical have been combined to an MDL in the Southern District of Indiana.

Attorneys at Banville Law have many years of experience fighting large pharmaceutical companies in pursuit of justice for victims who have been affected by companies that have put dangerous drugs and devices into the market. The firm strongly believes that victims are entitled to the compensation they need and deserve. Banville Law is currently offering free consultations to those who believe they have been negatively affected by the use of an IVC filter. Qualifying individuals may be entitled to significant legal action and substantial financial compensation.

For more information on IVC filters, to ask questions or to schedule a consultation, contact an attorney at Banville Law by calling (888)-997-3792.

###

Contact TheProductLawyers.com:

Banville Law
888-997-3792
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60010604

June 13, 2016 – – As of May 24, 2016, the Victims Compensation Fund (VCF) has paid out over $1 billion to claimants since the VCF reopened in 2011, according to the Fund’s Special Master.

Parker Waichman LLP, a national law firm that has spent many years fighting to ensure that the heroes and survivors of the 9/11 terrorist attacks are never forgotten, comments on recent news involving benefits for these rescue workers and survivors. The VCF Special Master indicated that she was very pleased to report that, as of May 24, 2016, the VCF has paid over $1 billion dollars to claimants since the VCF reopened in 2011. This includes all payments made to date, partial or full, on Group A claims. “I am tremendously proud of the VCF team for reaching this milestone, and deeply touched by the calls and letters we have received from claimants expressing their appreciation for the VCF’s efforts.”

According to the Special Master, by end-of-day May 22, 2016, the VCF team authorized the final payment on 8,717 Group A claims. This means the team authorized full payment on all Group A claims except for those payments on which issues were encountered that might have prevented payments. The team continues to work to resolve these issues, according to the Special Master. Special Master Birnbaum added that, “Our partners in the Department of Justice (“DOJ”) and Treasury Department continue to be very supportive in moving payments through the required steps as quickly as possible to facilitate the actual payments to claimants.”

Parker Waichman LLP notes that, following approval of the $8.1 billion measure to renew the Zadroga 9/11 Health and Compensation Act, President Obama signed the bill into law on December 18, 2015, reauthorizing the Act. The Act includes the World Trade Center (WTC) Health Program and the VCF. The WTC Health Program provides medical treatment and monitoring and is extended for another 75 years to 2090 with $3.5 billion in funding to monitor and care for 73,000 responders and survivors. The VCF was set to expire October 1, 2016 and is extended for another five years to 2021 with $4.6 billion in funding.

The new law directs the VCF to issue full compensation to claimants with Group A Claims— those nearly 10,0000 claims for which a loss determination was made on or before December 17, 2015—which will be followed by payment Group B claims, the firm explains.

Group A payments must be made before the funds will be made available to pay Group B claims. According to the VCF, in part, if claims with unresolved issues prevent the Fund from making payments, it will authorize the claim payment and the DOJ accounting office will place those funds into an account for future payments and will enable the Fund to authorize all Group A funding, while confirming Group B fund availability. Among other tasks, Group B claims continue to be reviewed, claimants continue to be contacted for missing information, and more that 2,050 eligibility decisions have been made on Group B claims since January 2016. The Fund expects to render the first Group B loss determinations by end-of-June 2016.

“We are thrilled that the VCF is expediting payments to those individuals who already received their award letter and applaud the VCF for looking for ways to make the process even more efficient to benefit the remaining claimants,” said Mathew McCauley, Senior Litigation counsel at Parker Waichman.

Parker Waichman notes that responders and survivors were exposed to many hazardous substances—asbestos, pulverized cement, and other toxins and chemicals—which have been tied to serious, life-altering conditions, including asthma, obstructive pulmonary disease, gastroesophageal reflux disease, and over 50 types of cancer. At least 4,166 cancer diagnoses have been linked to exposure to the toxic cloud that hovered over Manhattan’s attack site and that number is expected to increase.

“These individuals selflessly answered the call for help during and following the attacks and survivors may not know they have a developed condition as a result of the attacks,” says Mr. McCauley. “These individuals now know that these benefits will remain open for them and their families.”

Parker Waichman vows to continue its efforts to safeguard these heroes and survivors and ensure that they receive their deserved Zadroga Act compensation. Please visit Parker Waichman’s website or call 1-800-LAW-INFO (1-800-529-4636) for additional information and assistance.

###

Contact Parker Waichman LLP:

Parker Waichman
516-466-6500
info@yourlawyer.com
6 Harbor Park Drive Port Washington, NY 11050

ReleaseID: 60010644

June 13, 2016 – A new Taxotere lawsuit (http://www.rxinjuryhelp.com/taxotere/lawsuit/) has been filed in the U.S. District Court, Southern District of Mississippi, by a woman who developed permanent alopecia, allegedly due to side effects associated with the chemotherapy agent. The Plaintiff claims that Sanofi-Aventis failed to adequately warn doctors and patients that Taxotere caused permanent hair loss at a far greater rate than other, equally effective chemotherapy drugs. (Case No. No. 3:16-404)

According to the May 31st complaint, the Plaintiff was diagnosed with left breast cancer with lymph node involvement in 2013, and underwent chemotherapy that included Taxotere. She claims that Sanofi’s failure to warn patients about the risk of disfiguring, permanent hair loss deprived thousands of women of the opportunity to make an informed decision about their cancer treatment. Among other things, the lawsuit notes that the words permanent alopecia or permanent hair loss did not appear in any Taxotere information available in the U.S., even though Sanofi had provided such information to doctors and patients in other countries.

“Our Firm has heard from a number of women who allegedly experienced similar disfiguring side effects while using Taxotere. While they were aware that their cancer treatment could result in temporary hair loss, plaintiffs who have filed Taxotere lawsuits maintain that they were not at all prepared for the possibility of permanent alopecia,” says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective medical devices and drugs. The Firm is now offering free Taxotere lawsuit evaluations to breast cancer patients and others whose hair failed to grow back following chemotherapy with this chemotherapy medication

Taxotere and Hair Loss
Taxotere (docetaxel) was granted U.S. regulatory approval in 1996 to treat breast cancer, and is now indicated to treat a number of cancers, including head and neck cancer, gastric cancer, prostate cancer and non-small cell lung cancer. However, it wasn’t until December 2015 that any information regarding permanent hair loss was included on the U.S. label.

Taxotere lawsuit plaintiffs claim that in the late 1990s, Sanofi and other defendants were aware of a study indicating that 9.2 percent of patients who were treated with the medication had persistent alopecia for up to 10 years or longer. Yet, in the U.S., patients and doctors were only provided with a “generic, vague and insufficient” warning that “hair generally grows back.” Plaintiffs also point out that in 2006, a Denver-based oncologist had observed that an increased percentage of his patients who had been treated withTaxotere suffered from permanent hair loss for years after discontinuing the drug,

Taxotere cancer patients who allegedly experienced permanent baldness following chemotherapy with this medication may be entitled to compensation for their emotional distress and other damages. To learn more about filing a Taxotere lawsuit, please visit Bernstein Liebhard LLP’s website, or call 800-511-5092 to arrange for a free, no obligation case review.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3.5 billion on behalf of our clients. Bernstein Liebhard LLP is honored to once again be named to The National Law Journal’s “Plaintiffs’ Hot List,” recognizing the top plaintiffs firms in the country. This year’s nomination marks the thirteenth year the firm has been named to this prestigious annual list.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2016 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP
info (at)consumerinjurylawyers(dot)com
http://www.rxinjuryhelp.com/
https://plus.google.com/115936073311125306742?rel=author

GET IN TOUCH
Sandy Liebhard
RX Injury Help
800-511-5092
http://www.rxinjuryhelp.com/

Release ID: 246908

June 13, 2016 – – TheProductLawyers.com reports on recent suits filed against manufacturers concerning the side effects associated with IVC filters. Reports indicate that Boston Scientific and Cook Medical were hit with another lawsuit in early May concerning the devices. The Kentucky suits (5:16-cv-00065 and 5:16-cv-00066) accuse the companies of making faulty devices that caused blockages in patients with deep vein thrombosis. Both plaintiffs claim to have suffered severe pain after the filter was implanted.

IVC filters are used in patients to “catch” blood clots before they reach the pulmonary artery. In 1979, only 2,000 patients had the medical devices implanted to reduce the risk of pulmonary embolism. By 2007, nearly 167,000 IVC filters were being used to trap clots before they reached the lungs.

Since then, a number of patients have claimed that the devices cause serious adverse side effects. Patients have filed lawsuits against companies such as C.R. Bard and Cook Medical claiming that the devices broke apart inside their bodies, “migrating” toward internal organs, puncturing vital tissues and often causing irreparable damage. Many patients injured by IVC filters have joined a growing litigation, claiming device manufacturers did not adequately warn patients of the risks and continued to market the device despite its allegedly defectively design. Cases have been combined into Multidistrict Litigations in the U.S. District Court of Arizona and the Southern District of Indiana.

Attorneys at Banville Law have years of experience fighting large pharmaceutical companies in pursuit of justice for victims. The firm is currently offering free consultations to those who believe they have been negatively affected by the use of an IVC filter. Qualifying individuals may be entitled to significant legal action and substantial financial compensation.

For more information on IVC filters, to ask questions or to schedule a consultation, contact an attorney at Banville Law by calling (888)-997-3792.

###

Contact TheProductLawyers.com:

Banville Law
888-997-3792
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60010603

June 13, 2016 – – TheProductLawyers.com reports on a commonly cited side effect in patients using inferior vena caval (IVC) filters. Device migration, according to the National Library of Medicine, occurs when the device moves from its original deployed position to another part of the IVC. It can move to areas including heart valves, right ventricle or pulmonary outflow tract and, in those cases, may require surgery for removal.

IVC filters are small, metal devices designed to stop a blood clot from traveling to the lungs. The device resembles a metal cage and is surgically inserted into a patient’s inferior vena cava, the vein that takes blood back to the heart and lungs. The devices are typically used to help people recovering from accidents or surgeries and are given to individuals who are unable to take anticoagulants. The device was introduced in 1979, and its use increased continuously through the years. By 2012, doctors inserted approximately 259,000 filters in patients.

Since then, a number of complications have been associated with the devices, which are manufactured by companies including Cook Medical and C.R. Bard. Other than device migration, adverse events have included filter perforation, filter fracture and detached device components which can cause serious health problems for patients.

A number of patients who have claimed to suffer from such complications have filed legal claims against manufacturers for poor design, manufacturing and failing to warn of risks. Lawsuits against Bard were first filed in 2012 in California and Pennsylvania state courts and were combined into a Multidistrict Litigation (MDL) Panel in the U.S. District Court of Arizona in 2015. Those cases against Cook Medical have been combined to an MDL in the Southern District of Indiana.

Attorneys at Banville Law have years of experience fighting large pharmaceutical companies in pursuit of justice for victims. The firm is currently offering free consultations to those who believe they have been negatively affected by the use of an IVC filter. Qualifying individuals may be entitled to significant legal action and substantial financial compensation.

For more information on IVC filters, to ask questions or to schedule a consultation, contact an attorney at Banville Law by calling (888)-997-3792.

###

Contact TheProductLawyers.com:

Banville Law
888-997-3792
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60010602